Pharm-Olam: Phase III Pulmonary Arterial Hypertension study completed
A case study by Pharm-Olam for a Phase III study designed to address the efficacy and safety for a compound for pulmonary arterial hypertension patients.
A case study by Pharm-Olam for a Phase III study designed to address the efficacy and safety for a compound for pulmonary arterial hypertension patients.
Pharm-Olam was selected to provide development services for a Phase III study, which was designed to address the efficacy and safety for a compound for pulmonary arterial hypertension patients.
To view the case study and the lessons learned in this study, click here
Let us partner with your team on bringing new therapies to light. Get in touch to get started.